 Cholecalciferol
"Cholecalciferol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Derivative of 7-dehydroxycholesterol formed by ULTRAVIOLET RAYS breaking of the C9-C10 bond. It differs from ERGOCALCIFEROL in having a single bond between C22 and C23 and lacking a methyl group at C24.
| Descriptor ID |
D002762
|
| MeSH Number(s) |
D04.808.247.222.159 D04.808.247.808.146 D04.808.812.768.196 D10.570.938.146
|
| Concept/Terms |
Cholecalciferol- Cholecalciferol
- Calciol
- (3 beta,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
- Vitamin D 3
- Vitamin D3
|
Below are MeSH descriptors whose meaning is more general than "Cholecalciferol".
Below are MeSH descriptors whose meaning is more specific than "Cholecalciferol".
This graph shows the total number of publications written about "Cholecalciferol" by people in this website by year, and whether "Cholecalciferol" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2013 | 1 | 0 | 1 | | 2017 | 1 | 0 | 1 | | 2023 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Cholecalciferol" by people in Profiles.
-
O'Sullivan B, Ounpraseuth S, James L, Majure M, Lang J, Hu Z, Simon A, Bickel S, Ely B, Faricy LE, Garza M, Greer M, Hsia D, Jefferson A, Knight L, Lee J, Liptzin D, Haktanir Abul M, Perry TT, Prior F, SanGiovanni C, Tam-Williams J, Wu B, Snowden J. Vitamin D Oral Replacement in Children With Obesity Related Asthma: VDORA1 Randomized Clinical Trial. Clin Pharmacol Ther. 2024 02; 115(2):231-238.
-
Khan QJ, Kimler BF, Reddy PS, Sharma P, Klemp JR, Nydegger JL, Yeh HW, Fabian CJ. Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms in women with breast cancer receiving adjuvant letrozole. The VITAL trial. Breast Cancer Res Treat. 2017 Nov; 166(2):491-500.
-
Tannour-Louet M, Lewis SK, Louet JF, Stewart J, Addai JB, Sahin A, Vangapandu HV, Lewis AL, Dittmar K, Pautler RG, Zhang L, Smith RG, Lamb DJ. Increased expression of CYP24A1 correlates with advanced stages of prostate cancer and can cause resistance to vitamin D3-based therapies. FASEB J. 2014 Jan; 28(1):364-72.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|